Terns Pharmaceuticals, Inc. (TERN)

Terns Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	524.75	161.44	79.93	143.24	47.7
Short-Term Investments	494.24	196.73	183.51	139.88	118.28
Cash & Short-Term Investments	1,019	358.16	263.44	283.11	165.98
Cash Growth	184.50%	35.96%	-6.95%	70.57%	121.74%
Other Current Assets	5.21	3.95	3.99	2.07	0.95
Total Current Assets	1,024	362.11	267.43	285.19	166.93
Net Property, Plant & Equipment	0.88	1.47	1.03	1.8	1.05
Other Long-Term Assets	-	0.35	0.06	0.04	0.09
Total Assets	1,025	363.93	268.52	287.03	168.07
Accounts Payable	1.72	2.15	2.52	1.65	2.13
Accrued Expenses	14.22	13.07	8.83	6.16	4.69
Current Portion of Leases	0.47	0.43	0.6	0.66	-
Total Current Liabilities	16.41	15.65	11.94	8.47	6.82
Long-Term Leases	0.45	0.92	-	0.54	0.16
Other Long-Term Liabilities	1.7	1.49	1.21	1.07	0.79
Total Long-Term Liabilities	2.14	2.41	1.21	1.62	0.95
Total Liabilities	18.55	18.06	13.15	10.08	7.77
Common Stock	0.01	0.01	0.01	0.01	0
Additional Paid-in Capital	1,524	767.62	588.01	520.18	342.71
Accumulated Other Comprehensive Income	0.26	-0.28	-0.02	-0.82	-0.34
Retained Earnings	-517.69	-421.48	-332.63	-242.42	-182.07
Shareholders' Equity	1,007	345.87	255.37	276.94	160.3
Total Liabilities & Equity	1,025	363.93	268.52	287.03	168.07
Total Debt	0.92	1.35	0.6	1.21	0.16
Net Cash (Debt)	1,018	356.82	262.84	281.91	165.82
Net Cash Growth	185.32%	35.76%	-6.77%	70.01%	168.52%
Net Cash Per Share	10.93	4.49	3.69	7.82	7.30
Book Value	1,007	345.87	255.37	276.94	160.3
Book Value Per Share	10.80	4.35	3.58	7.69	7.06
Tangible Book Value	1,007	345.87	255.37	276.94	160.3
Tangible Book Value Per Share	10.80	4.35	3.58	7.69	7.06

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q